Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03670524 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project

Study acronym: HEAL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Oct 1, 2025 to Oct 1, 2027v6 Show 4 more changesShow less
    • Primary endpoint revised
    • Study completion date: Oct 30, 2026 to Oct 30, 2028
    • Secondary endpoints revised (28)
    • Site contact updated
  2. Site contact updatedv5
  3. Primary completion date: Oct 1, 2023 to Oct 1, 2025
    • Study completion date: Oct 30, 2025 to Oct 30, 2026
    v4
  4. Site contact updatedv3
  5. Primary completion date: Oct 31, 2018 to Oct 1, 2023
    • Enrollment target: 700 to 835
    • Study completion date: Oct 30, 2020 to Oct 30, 2025
    • Secondary endpoints revised (28)
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.
Trial Details
NCT Number NCT03670524
Lead Sponsor University of Louisville
Collaborators: National Institute of Environmental Health Sciences (NIEHS), The Nature Conservancy
Conditions
(from sponsor)		 Cardiovascular Diseases, Metabolic Health
Related terms Cardiovascular Diseases
Enrollment 835 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov